Teva Pharmaceutical Industries has launched Escitalopram Oxalate Tablets, the generic version of Lexapro tablets.
Subscribe to our email newsletter
Escitalopram Oxalate Tablet is the generic version of Forest Laboratories’ depression and generalized anxiety disorder treatment tablets.
Teva has received a 180-day period of marketing exclusivity as it is the first company to file an abbreviated new drug application(ANDA) containing a paragraph IV certification for the product.
The brand product had annual sales of approximately $2.9bn in the US, based on IMS sales data.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.